Thanks, John. We continue to believe the outlook for the rest of 2023 and 2024 in the sponsor-backed direct lending market is positive. Deal flow continues to be down overall, as valuation expectations reset in the world of higher base rates, but there are pockets of activity in our defensive growth verticals where we have the opportunity to make loans at attractive yields while remaining very selective. Yield structures remain compelling, with leverage levels meaningfully below peak levels and significant sponsor equity contributions representing the vast majority of the capital structures. We remain bullish on the medium- and long-term outlook for M&A, given the magnitude of dry powder for private equity and the ongoing need to return capital to LPs as well as the general maturity wall-facing borrowers. We saw a bit of a flurry of deal activity post Labor Day, including some opportunistic issuance but it continues to be episodic at the moment. Given our large portfolio of over 100 unique borrowers, we continue to see good opportunities to make incremental loans to existing well-performing portfolio companies seeking to pursue accretive M&A. Despite lower overall deal volume, the direct lending market remains the primary market for sponsors, while the syndicated market has reopened, it is practically only open for select issuers with higher ratings. Ongoing market volatility continues to push borrowers toward the more certain execution of a direct lending deal. Page 17 presents an interest rate analysis that provides insight into the positive effect of increasing base rates on NMFC's earnings. As a reminder, the NMFC loan portfolio is 88% floating rate and 12% fixed rate, while our liabilities are 50% fixed rate and 50% floating rate. Moving on to Page 18. In Q3, we continued our focus on modest deleveraging towards the middle of our 1time to 1.25 times debt-to-equity range. As a result, outside of some modest DDTL draws, we actually experienced net repayment activity, as several borrowers repaid due to re-financings or M&A. I'd highlight that two of the repayments were second lien positions, whereby strong performance enables both companies to take out the second lien with incremental first lien. Given the high base rate environment, the impact of minor deleveraging has not impeded our ability to significantly outearn our regular dividend. As I discussed in the market overview, we continue to see compelling opportunities, and post quarter end have received a few additional repayments that should provide some available capital for deployment into our highest conviction deals. In addition to the $10.8 million EaglePicher repayment that John mentioned, we also received a post-quarter end repayment of our $67.5 million position in PhyNet, a dermatology practice management business. Turning to Page 19. We show that our asset mix is consistent with prior quarters where about two-thirds of our investments, inclusive of first lien, SLPs and net lease are senior in nature. Approximately 8% of the portfolio is comprised of our equity positions, the largest of which are shown on the right side of the page. As mentioned in prior quarters, we hope to monetize certain of these equity positions in the medium term and rotate those dollars into cash-yielding assets. Our net lease portfolio, while only 4% of the portfolio continues to be a strong performer, and we thought it was worth a brief refresher on our strategy. We enter into sale-leaseback transactions for operationally critical properties with creditworthy tenants in our core defensive growth verticals. We like the longer duration nature of the asset class, the annual rent escalators as well as the downside protection associated with owning the physical real estate. We've generated $41 million of realized gains to date in the strategy and a weighted average cash yield of approximately 11%. Page 20 shows the current portfolio at a glance. We own 70 operationally essential and geographically diversified properties, including manufacturing facilities, pharmaceutical manufacturing and packaging facilities and warehouses that are leased to 13 tenants. We have no office or retail exposure. Page 21 shows that the average yield of NMFC's portfolio has increased from 11.6% in Q2 to 11.8% for Q3, primarily due to the higher for longer shift in the base rate curve. Generally speaking, spreads remain attractive and support our net investment income target. Page 22 highlights the scale and credit trends of our underlying borrowers. As you can see, the weighted average EBITDA of our borrowers has increased over the last several quarters to $147 million. While we first and foremost concentrate on how an opportunity maps against our defensive growth criteria and internal new knowledge, we believe that larger borrowers tend to be marginally safer, all else equal. We also show the relevant leverage and interest coverage stats across the portfolio. Portfolio company leverage has been consistent over the last several quarters. Loan to values continue to be quite compelling, and the current portfolio has an average loan to value of 42%. From an interest coverage perspective, we've continued to see modest compression as base rates rise. The weighted average interest coverage on the portfolio declined slightly to 1.5 times from 1.6 times last quarter. We expect interest coverage ratios to stabilize, and note that we've seen sponsors continue to proactively support company liquidity and continued M&A activity. This is a great indication that our portfolio consists of companies that are performing well and that are able to attract additional investment and healthy valuations. Finally, as illustrated on Page 23, we have a diversified portfolio across 110 portfolio companies. The Top 15 investments inclusive of our SLP funds and net lease account for about 42% of total fair value and represents our highest conviction names. I will now cover our financial results. For more details, please refer to our quarterly report on Form 10-Q that was filed yesterday with the SEC. As shown on Slide 24, the portfolio had approximately $3.1 billion in investments at fair value on September 30th and total assets of $3.3 billion, with total liabilities of $2 billion, of which total statutory debt outstanding was $1.6 billion; excluding $300 million of drawn SBA-guaranteed debentures. Net asset value of $1.3 billion or $13.06 per share was down slightly compared to the prior quarter. At quarter end, our statutory debt-to-equity ratio was 1.21 times to 1 and 1.16 times net of available cash on the balance sheet, consistent with the balance sheet deleveraging I mentioned previously. On Slide 25, we show our quarterly income statement results. For the current quarter, we earned total investment income of $94.1 million, a 20% increase over prior year. Total net expenses were approximately $53.7 million, an 18% increase over prior year. As a reminder, the investment adviser has committed to a management fee of 1.25% for the 2023 and 2024 calendar years. The investment adviser has also pledged to reduce this incentive fee, if and as needed, during this period to fully support the $0.32 per share regular quarterly dividend. It is important to note that the investment adviser cannot recoup fees previously waived. Our adjusted NII for the quarter was $0.40 per weighted average share, which meaningfully exceeded our Q3 regular dividend of $0.32 per share. As Slide 26 demonstrates, 99% of our total investment income is recurring this quarter, given the minimal fees earned in Q3. You will see historically that over 90% of our quarterly income is recurring in nature and on average; over 80% of our income is regularly paid in cash. We believe this consistency shows the stability and predictability of our investment income. Importantly, over 99% of our quarterly noncash income is generated from our green rated names. Turning to Slide 27. The red line shows the coverage of our regular dividend. This quarter, adjusted NII exceeded our Q3 regular dividend by $0.08 per share. For Q4 2023, our Board of Directors has again declared a regular dividend of $0.32 per share as well as a supplemental dividend of $0.04 per share. On Slide 28, we highlight our various financing sources and diversified leverage profile. Taking into account SBA guaranteed debentures, we had $2.2 billion of total borrowing capacity at quarter end, with $313 million available on our revolving lines subject to borrowing base limitations. We have a valuable mix of fixed and floating rate debt, and the 50% of fixed rate debt continues to be an earnings tailwind. As a reminder, covenants under both of our Wells Fargo and Deutsche Bank credit facilities are generally tied to the operating performance of the underlying businesses that we lend to, rather than the marks of our investments at any given time, which we think is particularly important during more volatile times. Finally, on Slide 29, we show our leverage maturity schedule. As we've diversified our debt issuance, we've been successful at laddering our maturities to manage liquidity. Post quarter end, we have successfully amended both of our Wells Fargo and Deutsche Bank credit facilities to extend maturities to 2028 and 2027, respectively. We additionally upsized and extended our management company revolver maturity to 2027. Pro forma for that, over 60% of our debt matures in or after 2027. Our multiple investment-grade credit ratings provide us access to various unsecured debt markets that we continue to explore to further ladder our maturities in the most cost-efficient manner. With that, I would like to turn the call back over to John.